¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"NATO advanced study institutes series. Series A, Life sciences."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • series limit
    °è¿­±ØÇÑ
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • average life expectancy
    Æò±Õ¿©¸í
  • basic life support
    ±âº»¼Ò»ý¼ú
  • basic trauma life support
    ±âº»¿Ü»ó¼Ò»ý¼ú
  • biologic half-life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • half-life
    ¹Ý°¨±â
  • intrauterine life
    ÀڱþȻýȰ, Àڱó»»ýȰ
  • life
    »ýȰ
  • life annuity
    Á¾½Å¿¬±Ý
  • life cycle
    »ýȰÁÖ±â
  • life expectancy
    ±â´ë¿©¸í
  • life instinct
    »îº»´É, »ýº»´É
  • life line
    1. »ý¸íÀüÈ­ 2. »ý¸í±¸Á¶¼±
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population study
    Àα¸Á¶»ç
  • prospective study
    ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
  • prospective cohort study
    ÀüÇâÄÚȣƮ¿¬±¸
  • retrospective study
    ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸, ȸ°í¿¬±¸
  • retrospective cohort study
    ÈÄÇâÄÚȣƮ¿¬±¸
  • single blinding study
    ´Ü¼ø¸Í°Ë¹ý
  • urodynamic study
    ¿ä¿ªµ¿Çа˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • life expectancy
    ¿©¸í, ³²Àº¼ö¸í
  • mean life expectancy
    Æò±Õ¿©¸í
  • half-life
    ¹Ý°¨±â
  • intrauterine life
    Àڱó»»ýȰ
  • life instinct
    »îº»´É, »ýº»´É
  • life
    »ýȰ
  • life annuity
    Á¾½Å¿¬±Ý
  • life expectancy
    ±â´ë¿©¸í
  • life line
    »ý¸íÀüÈ­, »ý¸í±¸Á¶¼±
  • life table
    »ý¸íÇ¥
  • life insurance medicine
    »ý¸íº¸ÇèÀÇÇÐ
  • life insurance method
    »ý¸íº¸Çè¹ý
  • physical half life
    ¹°¸®Àû¹Ý°¨±â
  • shelf life
    ÀúÀå±â°£, º¸°ü±â°£
  • mean life span
    Æò±Õ¼ö¸í
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • air study
    °ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
  • arterial blood gas study
    µ¿¸ÆÇ÷ °¡½ººÐ¼®
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • phase 1 study
    ÀÓ»óÁ¦1»ó½ÃÇè.
  • pilot study
    ¿¹ºñ½ÇÇè.
  • population study
    Àα¸Á¶»ç
  • preclinical study
    ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
  • pressure flow study
    ¾Ð·ù·® Á¶»ç
  • pressure-perfusion study
    ¾Ð·Â°ü·ù°Ë»ç
  • prospective study
    °èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
  • real time study
    ½Ç½Ã°£ °Ë»ç
  • Hofmeister s series =lyotropic s.
    È£ÇÁ¸¶À̽ºÅͰ迭(¡­Í§æê).
  • aliphatic series
    Áö¹æ°è¿­.
  • arithmetic series
    µîÂ÷±Þ¼ö.
  • aromatic series
    ¹æÇâÁ·¿­(¡­ðéæê).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cohort study
    ÄÚ¿ÀÆ®¿¬±¸(ÊÙËçË´), Æø·ÎºñÆø·Î¿¬±¸.
  • controlled clinical study
    (Ãß°èÇÐÀû) °ü¸®È­(Ì§Ë­Ì°ËøË´ËöÌ´)(ÀÓ»ó)½ÃÇè( ËöË×ËàÌ´).
  • double-blind study
    ÀÌÁ߸ͰË.
  • family study
    °¡Á·Á¶»ç(¿¬±¸)
  • first pass study
    ÀÏÂ÷Åë°ú°Ë»ç.
  • follow-up study
    ÃßÀûÁ¶»ç
  • infection control study
    °¨¿°°ü¸®¿¬±¸
  • microbiologic study
    ¹Ì»ý¹°ÇÐÀû °Ë»ç
  • molecular genetic study
    ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
  • nested case control study
  • phase 1 study
    ÀÓ»óÁ¦1»ó½ÃÇè.
  • pilot study
    ¿¹ºñ½ÇÇè.
  • population study
    Àα¸Á¶»ç
  • preclinical study
    ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
  • pressure flow study
    ¾Ð·ù·® Á¶»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lyotropic series
    À̾װ迭(ìÆäû֪ͧ)
  • radioactive series
    ¹æ»ç¼º °è¿­(Û¯ÞÒàõ֪ͧ)
  • Trappe's eluotropic series
    Æ®¶óÆä ¿ë¸®¼­¿­(éÁ×îßíÖª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • study of choice
    ÃÖ¼±ÀÇ °Ë»ç
  • gallbladder series
    ´ã³¶Á¶¿µ°Ë»ç
  • gastrointestinal series
    À§Àå°üÁ¶¿µ¼ú
  • small bowel series
    ¼ÒÀåÁ¶¿µ¼ú
  • upper gastrointestinal series
    »óºÎÀ§Àå°üÁ¶¿µ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ATLS acute tumor lysis syndrome; advanced trauma life support
PALS parietolateral lymphocyte sheath; pediatric advanced life support; prison-acquired lymphoproliferati...
IASHS Institute for Advanced Study in Human Sexuality
NIH National Institutes of Health
HHMI Howard Hughes Medical Institutes
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
A.I.I.M.S. All India Institute of Medical Sciences
NIEHS National Institute of Environmental Health Sciences
SEC Series elastic component
LSS Life Span Study
Study 1 study
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • average length of life
    Æò±Õ ¼ö¸í
  • cohort life table
    ÄÚȣƮ »ý¸íÇ¥
  • duration of life
    ¼ö¸í
  • elimination half-life
    ¼Ò½Ç ¹Ý°¨±â
  • expectancy of life
    ¿©¸í
  • fatigue life
    ÇÇ·Î ¼ö¸í
    ÇÇ·Î Æò°¡¹ýÀÇ Çϳª. ¹Ýº¹ ÀÀ·ÂÀÌ ÀÏÁ¤ÇÒ ¶§¿¡ ÆÄ±«¸¦ ÀÏÀ¸Å°´Â ÃÖ¼ÒÀÇ ¹Ýº¹ Ƚ¼ö.
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • life
    »ý¸í
    »ý¸í Çö»óÀÇ ÃÑĪ. À¯±âü°¡ ¹«±â¹°°ú´Â °ü°è¾ø´Â ÈûÀ̳ª ±â´ÉÀ» ³ªÅ¸³»´Â °æ¿ìÀÇ ¸·¿¬ÇÑ °³³ä. ÀϹÝÀûÀ¸·Î »ý¸íü´Â ¿©·¯ °¡Áö Á¤µµÀÇ Â÷ÀÌ´Â ÀÖÀ¸³ª ±â±¸È­, ÇÇÀڱؼº, ¿îµ¿, ¹ßÀ°, »ý½Ä, ÀûÀÀ µîÀÇ Æ¯Â¡À» ³ªÅ¸³½´Ù.
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
    »ý¹°ÀÇ »ýȰ»ç¿¡ ÀÖ¾î ÀÏ·ÃÀÇ Çö»ó.
  • life expectancy
    ¼ö¸í
    ¾î¶² ¿¬·É ¶Ç´Â ¿¬·ÉÃþÀÇ »ç¶÷ÀÌ ´õ »ì ¼ö ÀÖ´Â °¡´É¼ºÀÌ ÀÖ´Â ¿¬¼ö·Î¼­ Åë°èÀûÀÎ Æò±Õ¿¡ ±âÃÊÇÑ °Í.
  • life habit
    »ýȰ ½À¼º, »ýȰ ½À°ü
    °°Àº »óȲ¿¡¼­ ¹Ýº¹µÈ ÇൿÀÇ ¾ÈÁ¤È­, ÀÚµ¿È­µÈ ¼öÇà. Á¼Àº Àǹ̷δ ¹Ýº¹¿¡ ÀÇÇÑ ±ÙÀ° ¿îµ¿À̳ª °Ç ¿îµ¿ÀÌ Á¤ÇüÈ­µÇ´Â °ÍÀ» ¸»ÇÏÁö¸¸, ÁÖ±âÀûÀ¸·Î ¹Ýº¹ÇÏ´Â ½Ä»ç³ª ¼ö¸é ½À°ü, dz¼Ó, ¹®È­ µî ³ÐÀº °ü½À¿¡ ´ëÇØ¼­µµ ½À°üÀ̶ó°í ÇÑ´Ù. ½À°üÀ̶õ Á¤ÇüÀûÀ̸ç ÀÚµ¿ÀûÀ¸·Î ¹ß»ýÇÏ´Â ¹ÝÀÀÀ̶ó´Â Á¡¿¡¼­ ÀÚÀ¯·ÎÀÌ º¯È­ÇÏ´Â ÀǵµÀû ¹ÝÀÀ°ú ±¸º°µÈ´Ù. ¶ÇÇÑ ½À°üÀº ½ÀµæµÈ °á°ú¶ó´Â Á¡¿¡¼­ ¼±ÃµÀû ¹ÝÀÀ°ú ±¸º°µÈ´Ù. ¼ú, ´ã¹è ¶Ç´Â ƯÁ¤ ¾à¹°ÀÇ »ó¿ëÀ̳ª, ¿­´ë, ÇÑ´ë¿¡¼­ÀÇ Àå±â »ýȰ, ¿ìÁÖºñÇà¿¡¼­ÀÇ ±â¾ÐÀ̳ª ¹«Áß·Â »óÅ¿¡ ´ëÇÑ ÀûÀÀ µî Ư¼öÇÑ ¿ÜÀûÀÎ »óȲ¿¡ ´ëÇÑ ¹ÝÀÀÀÇ Á¤ÇüÈ­´Â¡®¼øÈ­¡¯¶ó°í ÇÏ¿© ½À°ü°ú ±¸º°ÇÏ¿©¾ß ÇÑ´Ù.
  • life insurance
    »ý¸í º¸Çè
    »ç¶÷ÀÇ »ç¸Á ¶Ç´Â »ýÁ¸À» º¸Çè»ç°í·Î ÇÏ´Â ÀÏüÀÇ º¸Çè. Àκ¸ÇèÀÇ ´ëÇ¥ÀûÀÎ °ÍÀÌ´Ù. º¸ÇèÀÚ°¡ º¸Çè°è¾àÀÚ ¶Ç´Â Á¦3ÀÚÀÇ »ý»ç¿¡ °üÇÏ¿© ÀÏÁ¤ÇÑ ±Ý¾×
  • life insurance medicine
    »ý¸í º¸Çè ÀÇÇÐ
  • life phase
    »ýȰ»ó
  • life span
    ¼ö¸í
    °³Ã¼ÀÇ »ýÁ¸ ±â°£.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
blinded study Clinical trials of drugs are often done blinded so that the patient does not know (is blinded as to) whether they are receiving the product being tested or the control/placebo to ensure that the results of a study are not affected by a possible placebo effect (by the power of suggestion).
(12 Dec 1998)
blind study A study in which the experimenter is unaware of which group is subject to which procedure.
(05 Mar 2000)
case-control study <epidemiology> A study in which the risk factors of people with a disease are compared with those without a disease.
It is an epidemiological method that begins by identifying persons with the disease or condition of interest (the cases) and compares their past history of exposure to identified or suspected risk factors with the past history of similar exposures among persons who resemble the cases but do not have the disease or condition of interest (the controls).
The relationship of an attribute to the disease can therefore be examined by comparing affected and non-affected individuals with regard to the frequency or levels of the attribute in each group.
(05 May 2002)
retrospective study <epidemiology> A study in which people are enrolled and then have their history of risks, infections or disease measured.
(05 Dec 1998)
rosenzweig picture-frustration study A projective test depicting cartoon-like characters in frustrating situations. The scoring of the subject's responses indicates the direction of hostility or aggression, that is, whether he blames himself, the other person, or the set of circumstances.
(12 Dec 1998)
cohort study A study using epidemiological methods, such as a clinical trial, in which a cohort with a particular attribute (e.g., smokers, recipients of a drug) is followed prospectively and compared for some outcome (e.g., disease, cure) with another cohort not possessing the attribute.
(05 Mar 2000)
pioped study <radiology> 251 patients with documented PE on pulmonary angiograms were given V/Q scans: 102 high probability, 105 intermediate probability, 39 low probability, 5 normal or near-normal
(12 Dec 1998)
multicenter study A controlled study executed by several cooperating institutions.
(12 Dec 1998)
multigeneration study Toxicity test in which at least 3 generations of the test organisms are exposed to the substance being assessed. Exposure is usually continuous.
Any medical study which follows a family of people through several generations.
(09 Oct 1997)
crossover study <statistics> A study that compares two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. Usually refers to a study in which the subject is switched from the experimental to the control procedure (or vice versa).
In the case of two treatments, a and b, half the subjects are randomly allocated to receive these in the order a, b and half to receive them in the order b, a.
A criticism of this design is that effects of the first treatment may carry over into the period when the second is given.
With this type of study, every patient serves as his or her own control.
(21 Jun 2000)
cross-sectional study <epidemiology> A study in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with longitudinal studies which are followed over a period of time.
Synonym: horizontal study.
(18 Jul 2002)
preclinical study A study to test a drug, procedure or other medical treatment in animals. The aim is to collect data in support of safety. Preclinical studies are required before clinical trials can be started.
(12 Dec 1998)
prospective study <epidemiology> A study in which people are initially enrolled and then followed up at subsequent times.
(05 Dec 1998)
study 1. To apply the mind to; to read and examine for the purpose of learning and understanding; as, to study law or theology; to study languages.
2. To consider attentively; to examine closely; as, to study the work of nature. "Study thyself; what rank or what degree The wise Creator has ordained for thee." (Dryden)
3. To form or arrange by previous thought; to con over, as in committing to memory; as, to study a speech.
4. To make an object of study; to aim at sedulously; to devote one's thoughts to; as, to study the welfare of others; to study variety in composition. "For their heart studieth destruction." (Prov. Xxiv. 2)
Origin: OE. Studie, L. Studium, akin to studere to study; possibly akin to Gr. Haste, zeal, to hasten; cf. OF. Estudie, estude, F. Etude. Cf. Etude, Student, Studio, Study, v. I.
1. A setting of the mind or thoughts upon a subject; hence, application of mind to books, arts, or science, or to any subject, for the purpose of acquiring knowledge. "Hammond . . . Spent thirteen hours of the day in study." (Bp. Fell) "Study gives strength to the mind; conversation, grace." (Sir W. Temple)
2. Mental occupation; absorbed or thoughtful attention; meditation; contemplation. "Just men they seemed, and all their study bent To worship God aright, and know his works." (Milton)
3. Any particular branch of learning that is studied; any object of attentive consideration. "The Holy Scriptures, especially the new Testament, are her daily study." (Law) "The proper study of mankind is man." (Pope)
4. A building or apartment devoted to study or to literary work. "His cheery little study."
5. A representation or rendering of any object or scene intended, not for exhibition as an original work of art, but for the information, instruction, or assistance of the maker; as, a study of heads or of hands for a figure picture.
6. A piece for special practice. See Etude.
Source: Websters Dictionary
(01 Mar 1998)
study, crossover A type of clinical trial in which the study subjects receive each treatment in a random order. In this type of study, every patient serves as his or her own control.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • study
    ÇÏ´Ù;(´ë»çµîÀ»)¾Ï±âÇÏ´Ù
  • a series fo
    ÀÏ·ÃÀÇ
  • series
    ¿¬¼ÓµÈ °Í
  • actinide series
    ¾ÇƼ´Ïµå °è¿­;¹æ»ç¼±¿ø¼Ò
  • arithmetic series
    µîÂ÷±Þ¼ö
  • geometric series
    ±âÇÏ(µîºñ)±Þ¼ö
  • harmonic series
    Á¶È­ ±Þ¼ö
  • methane series
    ¸Þź ¿­
  • paraffin series
    ÆÄ¶óÇÉÁ·;¸Þź°è
  • power series
    ¸è±Þ¼ö
  • radioactive series
    ¹æ»ç¼º °è¿­;±«º¯ °è¿­
  • series
    ÀÏ·Ã;¿¬¼Ó;½Ã¸®Áî;¼ö¿­;±Þ¼ö;¿­;Åë;Á÷·Ä;(12À½ À½¾ÇÀÇ)À½·Ä;arithmetical ~ µîÂ÷ ±Þ¼ö
  • for one's life
    ÇÊ»çÀûÀ¸·Î
  • for the life of me
    ¾Æ¹«¸®Çصµ
  • half life
    ¹Ý°¨±â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á